US President Donald Trump on Monday signed an executive order that declares fentanyl a “weapon of mass destruction”, classifying the synthetic opioid as both a lethal narcotic and a potential chemical weapon under US law.
In a White House press release accompanying the order, the president underscored the drug’s lethality and the scale of the public health crisis it has caused. “Illicit fentanyl is closer to a chemical weapon than a narcotic. Two milligrams, an almost undetectable trace amount equivalent to 10 to 15 grains of table salt, constitutes a lethal dose. Hundreds of thousands of Americans have died from fentanyl overdoses”, the statement said.
The executive order itself adopts sweeping language. “As President of the United States, my highest duty is the defense of the country and its citizens. Accordingly, I hereby designate illicit fentanyl and its core precursor chemicals as Weapons of Mass Destruction (WMD).”
Read the complete order here.
The directive instructs both the Pentagon and the Department of Justice to take additional steps to disrupt the production and distribution of fentanyl, signalling a broader use of national security tools in what has traditionally been treated as a criminal and public health issue.
According to the White House, the designation “unleashes every tool to combat the cartels and foreign networks responsible for flooding communities with this deadly substance”. It also warns that fentanyl could be weaponised for “concentrated, large-scale terror attacks by organized adversaries”.
It remains unclear what immediate changes the designation will bring. Under existing US law, it is already a crime to threaten or attempt to use weapons of mass destruction. The Department of Homeland Security has historically defined such weapons as “radiological, chemical, biological, or other device that is intended to harm a large number of people”.
Legal analysts note that while the designation carries powerful symbolic weight, its practical effect will depend on how aggressively federal agencies reinterpret existing statutes and authorities.
The Trump administration’s assertion that fentanyl could be deployed in “concentrated, large-scale terror attacks by organized adversaries” has been met with scepticism among drug policy and security experts.
Jonathan Caulkins, a professor at Carnegie Mellon University who researches drugs, crime, terrorism and violence, questioned the premise, telling Stat News: “Neither terrorist organizations nor militaries are using fentanyl as a weapon. It is not obvious to me that this is a threat.”
Trump's executive order follows a series of hardline moves by the US administration. Earlier this year, the US government designated major drug cartels as foreign terrorist organisations, a step widely seen as laying the groundwork for military action against them.
Since early September, the administration has carried out more than 20 strikes against suspected drug vessels in the Caribbean and Pacific, operations that have reportedly killed more than 80 people.
However, military experts say that cartels operating maritime routes in the Caribbean are more typically associated with cocaine trafficking, while they largely route fentanyl to Europe rather than the United States. Little public evidence has been produced to show that the vessels targeted were carrying drugs.
Trump has nevertheless repeatedly threatened strikes on land in Venezuela, Colombia and Mexico as part of his campaign against drug trafficking. In a sweeping foreign policy strategy document published last week, he said his administration’s focus would be on reasserting US dominance in the Western Hemisphere.
Mexico remains the largest source of illicit fentanyl entering the United States, while many of the precursor chemicals used in its manufacture are sourced from China. Although fentanyl remains a leading cause of overdose deaths in the US, fatalities linked to the drug have begun to decline in recent years.
Despite this trend, Trump has continued to cite fentanyl as a central national threat, using it to justify tougher criminal penalties, aggressive trade policies and stricter immigration enforcement. The administration has also repeatedly — and falsely — blamed fentanyl trafficking on undocumented migrants.
Public health specialists have warned that the administration’s strategy risks overlooking the domestic addiction crisis driving demand for fentanyl. Critics argue that cuts to staffing and resources at federal agencies responsible for addiction treatment and drug policy have weakened the national response.
The administration has also moved to withhold funding from some harm reduction organizations, while proposed cuts to Medicaid — the program that provides healthcare to low-income Americans — have raised alarms among clinicians and advocates. Law enforcement and public health experts have cautioned that such reductions could severely undermine efforts to treat substance use disorders.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.